datopotamab deruxtecan
FDA Grants Accelerated Approval to Datroway for Some Patients With EGFR-Mutated NSCLC
The FDA granted accelerated approval to Datroway for some adults with locally advanced or metastatic EGFR-mutated ...
JUNE 25, 2025
Datopotamab Deruxtecan Shines in Metastatic Breast Cancer
In patients with inoperable or metastatic hormone receptor–positive (HR-positive), HER2-negative breast ...
NOVEMBER 22, 2023
Load more